|
S. No. |
Antimicrobial |
Control G1 |
G2 |
G3 10th day |
| 5th day |
10thday |
| 1 |
Amikacin |
R |
R |
R |
S |
| 2 |
Amoxicillin/K-clavulanate |
R |
R |
R |
R |
| 3 |
Ampicillin/Sulbactam |
R |
R |
R |
R |
| 4 |
Ampicillin |
R |
R |
R |
R |
| 5 |
Aztreonam |
R |
R |
R |
IB |
| 6 |
Cefazolin |
R |
R |
R |
R |
| 7 |
Cefepime |
R |
R |
I |
S |
| 8 |
Cefotaxime |
R |
R |
I |
IB |
| 9 |
Cefotetan |
R |
R |
R |
IB |
| 10 |
Cefoxitin |
R |
R |
R |
R |
| 11 |
Ceftazidime |
R |
R |
R |
IB |
| 12 |
Cefuroxime |
R |
R |
R |
R |
| 13 |
Ceftriaxone |
I |
I |
IB |
IB |
| 14 |
Cephalothin |
R |
R |
R |
R |
| 15 |
Chloramphenicol |
R |
R |
R |
I |
| 16 |
Ciprofloxacin |
S |
S |
S |
S |
| 17 |
Gatifloxacin |
S |
S |
S |
S |
| 18 |
Gentamicin |
R |
R |
R |
S |
| 19 |
Imipenem |
S |
S |
S |
S |
| 20 |
Levofloxacin |
S |
S |
S |
S |
| 21 |
Meropenem |
S |
S |
S |
S |
| 22 |
Moxifloxacin |
S |
S |
S |
S |
| 23 |
Nitrofurantoin |
R |
R |
R |
R |
| 24 |
Norfloxacin |
S |
S |
S |
S |
| 25 |
Piperacillin |
IB |
IB |
IB |
IB |
| 26 |
Tazobactam |
IB |
IB |
IB |
IB |
| 27 |
Ticarcillin |
IB |
IB |
IB |
IB |
| 28 |
Tobramycin |
R |
R |
R |
S |
| 29 |
Vancomycin |
S |
S |
S |
S |
|
| G stands for group; I: intermediate; S: susceptible; R: resistant; IB: inducible β-
lactamase. |
| Table 1: Effect of biofield treatment on S. marcescens to susceptibility
pattern of selected antimicrobials. |
